scispace - formally typeset
Open Access

ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof, +3 more
- Vol. 70, Iss: 1, pp 1-84
About
The article was published on 2017-01-01 and is currently open access. It has received 3603 citations till now. The article focuses on the topics: Management of atrial fibrillation.

read more

Citations
More filters
Journal ArticleDOI

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

TL;DR: Authors/Task Force Members: Piotr Ponikowski* (Chairperson) (Poland), Adriaan A. Voors* (Co-Chair person) (The Netherlands), Stefan D. Anker (Germany), Héctor Bueno (Spain), John G. F. Cleland (UK), Andrew J. S. Coats (UK)
Journal ArticleDOI

2018 ESC/EACTS Guidelines on myocardial revascularization.

TL;DR: Authors/Task Force Members: Franz-Josef Neumann* (ESC Chairperson) (Germany), Miguel Sousa-Uva* (EACTS Chair person) (Portugal), Anders Ahlsson (Sweden), Fernando Alfonso (Spain), Adrian P. Banning (UK), Umberto Benedetto (UK).
Journal ArticleDOI

2017 HRS / EHRA / ECAS / APHRS / SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Hugh Calkins, +60 more
- 01 Oct 2017 - 
TL;DR: This 2017 Consensus Statement is to provide a state-of-the-art review of the field of catheter and surgical ablation of AF and to report the findings of a writing group, convened by these five international societies.
References
More filters
Journal ArticleDOI

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group.

TL;DR: It is found that patients with pulmonary congestion, anterolateral Q wave infarction, or reduced ejection fraction at baseline were more likely to have CHF during follow-up than those without these markers of LVD, and diltiazem increased the frequency of late CHF as well as of cardiac events, but only in patients predisposed by LVD.
Journal ArticleDOI

Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis.

TL;DR: Ablation and pacing therapy improves a broad range of clinical outcomes for patients with medically refractory atrial fibrillation and the calculated 1-year mortality rates after this therapy are low and comparable with medical therapy.
Journal ArticleDOI

Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis

TL;DR: In patients with NVAF at increased risk for stroke or bleeding who are candidates for chronic anticoagulation, LAAC resulted in improved rates of hemorrhagic stroke, cardiovascular/unexplained death, and nonprocedural bleeding compared to warfarin.
Journal ArticleDOI

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.

TL;DR: Among patients with OAC-associated ICH, reversal of anticoagulation reversal and blood pressure (BP) with hematoma enlargement and resumption of OAC therapy was associated with lower risk of ischemic events, and these findings require replication and assessment in prospective studies.
Related Papers (5)